Font Size: a A A
Keyword [CD22]
Result: 1 - 19 | Page: 1 of 1
1. Primary Expression Of Anti-CD22 Humanize Engineering Multivalent And Miniantibody
2. The Study Of Genetic And Environmental Risk Factors And Gene-environment Interaction For SLE
3. Expression Of Co-receptor CD22 And CD72 On Peripheral B Lymphocytes In Patients With Guillian-Barre Syndrome
4. Biological Function Research Of A Mouse Anti Human CD22 Monoclonal Antibody HIB22 And Development Of Single Chain Fv Derived From HIB22 Hybridoma
5. Research Of Electromyography, Cerebrospinal Fluid And Peripheral Blood B Lymphocytes In Patients With Guillian-Barre Syndrome
6. The Clinical Significance Of Soluble CD22,a B-cell Activation Marker, And The Study About Its Mechanism
7. TNFR: Fc Fusion Protein Bio-similar Drugs Quality Comparable Preliminary Study Preliminary Inquiry & CD22 Monoclonal Antibody Effector Function
8. Study On The Effects Of Caveolin-1on ST6Gal-I Expression And Adhesion Ability Of Hepatocarcinoma Cell
9. CD22 Signal Abnormalities In The Pathogenesis Of Immune Related Pancytopenia
10. Construction Of T Cells Expressing Anti-CD19 And Anti-CD22 Antigen Chimeric Antigen Receptor And Their Combined Application In B-cell Malignancies
11. Optimizating The CD22 CAR Design And Studying The Ca2+ Signaling Dynamics In CAR-T Cells
12. Applications of phage-displayed antibody library for antibody discovery and engineering
13. The role of CD22 and Bim expression as determinants for the regulation of antigen-specific adaptive immune responses
14. Effects Of Lipopolysaccharide On CD22 Expression And Phagocytosis Of Microglia
15. A Study Of Infections Of R/R B-ALL Patients After Treated With Sequential Infusion Of Anti-CD19 And Anti-CD22 CAR T-cells
16. Construction Of Platelet-Targeted Drug-Loading System And The Study Of Its Effects On Burkitt’s Lymphoma
17. The Clinical And Mechanistic Study Of Synergistic Combination Of IFN-α With CD19/CD22 Bispecific Targeted CAR-T Cell Therapy In Relapsed And Refractory Bcell Acute Lymphoblastic Leukemia
18. Efficacy And Safety Of Anti-CD19/CD22 Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphoblastic Leukemia
19. Construction And Functional Evaluation Of CD19/CD22 Dual-Target Tandem-CAR T Cells
  <<First  <Prev  Next>  Last>>  Jump to